226 related articles for article (PubMed ID: 23412100)
1. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma.
Schache AG; Liloglou T; Risk JM; Jones TM; Ma XJ; Wang H; Bui S; Luo Y; Sloan P; Shaw RJ; Robinson M
Br J Cancer; 2013 Apr; 108(6):1332-9. PubMed ID: 23412100
[TBL] [Abstract][Full Text] [Related]
2. Utility of the Roche Cobas 4800 for detection of high-risk human papillomavirus in formalin-fixed paraffin-embedded oropharyngeal squamous cell carcinoma.
Pettus JR; Wilson TL; Steinmetz HB; Lefferts JA; Tafe LJ
Exp Mol Pathol; 2017 Feb; 102(1):47-49. PubMed ID: 27939577
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of p16
Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice.
Mirghani H; Casiraghi O; Amen F; He M; Ma XJ; Saulnier P; Lacroix L; Drusch F; Ben Lakdhar A; Saint Guily JL; Badoual C; Scoazec JY; Vielh P
Mod Pathol; 2015 Dec; 28(12):1518-27. PubMed ID: 26403782
[TBL] [Abstract][Full Text] [Related]
5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
6. HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients.
Robinson M; Schache A; Sloan P; Thavaraj S
Head Neck Pathol; 2012 Jul; 6 Suppl 1(Suppl 1):S83-90. PubMed ID: 22782227
[TBL] [Abstract][Full Text] [Related]
7. HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice.
Bussu F; Ragin C; Boscolo-Rizzo P; Rizzo D; Gallus R; Delogu G; Morbini P; Tommasino M
Head Neck; 2019 Apr; 41(4):1104-1111. PubMed ID: 30747478
[TBL] [Abstract][Full Text] [Related]
8. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.
Schlecht NF; Brandwein-Gensler M; Nuovo GJ; Li M; Dunne A; Kawachi N; Smith RV; Burk RD; Prystowsky MB
Mod Pathol; 2011 Oct; 24(10):1295-305. PubMed ID: 21572401
[TBL] [Abstract][Full Text] [Related]
9. RNAscope for in situ detection of transcriptionally active human papillomavirus in head and neck squamous cell carcinoma.
Wang H; Wang MX; Su N; Wang LC; Wu X; Bui S; Nielsen A; Vo HT; Nguyen N; Luo Y; Ma XJ
J Vis Exp; 2014 Mar; (85):. PubMed ID: 24637627
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland.
Craig SG; Anderson LA; Moran M; Graham L; Currie K; Rooney K; Robinson M; Bingham V; Cuschieri KS; McQuaid S; Schache AG; Jones TM; McCance D; Salto-Tellez M; McDade SS; James JA
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):31-38. PubMed ID: 31666283
[TBL] [Abstract][Full Text] [Related]
11. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus genotype and oropharynx cancer survival in the United States of America.
Goodman MT; Saraiya M; Thompson TD; Steinau M; Hernandez BY; Lynch CF; Lyu CW; Wilkinson EJ; Tucker T; Copeland G; Peters ES; Altekruse S; Unger ER
Eur J Cancer; 2015 Dec; 51(18):2759-67. PubMed ID: 26602016
[TBL] [Abstract][Full Text] [Related]
13. Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.
Fonmarty D; Cherrière S; Fleury H; Eimer S; Majoufre-Lefebvre C; Castetbon V; de Monès E
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):135-9. PubMed ID: 25687724
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
15. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
[TBL] [Abstract][Full Text] [Related]
16. In situ hybridization for high risk HPV E6/E7 mRNA in oropharyngeal squamous cell carcinoma.
Suresh K; Shah PV; Coates S; Alexiev BA; Samant S
Am J Otolaryngol; 2021; 42(1):102782. PubMed ID: 33171410
[TBL] [Abstract][Full Text] [Related]
17. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
18. High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer.
Carpén T; Sorsa T; Jouhi L; Tervahartiala T; Haglund C; Syrjänen S; Tarkkanen J; Mohamed H; Mäkitie A; Hagström J; Mattila PS
Cancer Immunol Immunother; 2019 Aug; 68(8):1263-1272. PubMed ID: 31240326
[TBL] [Abstract][Full Text] [Related]
19. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Anyplex II HPV28 Assay in the Detection of Human Papillomavirus in Archival Samples of Oropharyngeal Carcinomas.
Rollo F; Donà MG; Pichi B; Pellini R; Covello R; Benevolo M
Arch Pathol Lab Med; 2020 May; 144(5):620-625. PubMed ID: 31509455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
